{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:10:09Z","timestamp":1785769809760,"version":"3.56.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:p>Conflicting information exists in the literature regarding the relationship between HIV viral load suppression and immune suppression among people living with HIV (PLHIV) with coronavirus disease (COVID-19) comorbidity. We evaluated risk of in-hospital mortality among PLHIV with varying levels of immunosuppression and viral load in South Africa. We analyzed retrospectively collected individual-level cohort data from South Africa shared in the World Health Organization Global Clinic Platform comprising 3,10,522 hospitalized individuals, including 8191 PLHIV on antiretroviral therapy. Advanced disease was defined as CD4 counts of &lt;200 cells\/\u00b5L. The primary outcome was in-hospital mortality, defined as death within 28 days of hospital admission. Royston\u2013Parmar survival models were used to assess the association of viral load and CD4 counts with in-hospital mortality among PLHIV on antiretroviral therapy. Models were adjusted for demographic factors, COVID-19 severity, severe acute respiratory syndrome coronavirus-2 variants, and comorbidities. Among the 8191 PLHIV with available CD4 and viral load data, 77.2% had viral suppression, and 35.9% had CD4 counts &lt; 200 cells\/\u03bcL. Compared to HIV-negative individuals, PLHIV with CD4 &lt; 200 cells\/\u03bcL and viral load \u22651000 copies\/mL had a significantly higher risk of mortality (adjusted hazard ratio [aHR] 2.73, 95% CI: 2.45\u20133.04). Elevated mortality risk was also observed in PLHIV with CD4\u2005&lt;\u2005200 cells\/\u03bcL and viral load &lt; 1000 copies\/mL (aHR 2.01, 95% CI: 1.84\u20132.20), and those with CD4\u2005\u2265\u2005200 cells\/\u03bcL and viral load\u2005\u2265\u20051000 copies\/mL (aHR 1.47, 95% CI: 1.20\u20131.81). PLHIV with CD4\u2005\u2265\u2005200 cells\/\u03bcL and viral suppression had the lowest, but still significant, increased in-hospital mortality risk (aHR 1.27, 95% CI: 1.18\u20131.36). A substantial increased risk of in-hospital mortality occurs among PLHIV with advanced HIV disease and unsuppressed viremia hospitalized with COVID-19. These findings highlight the importance of prioritizing COVID-19 vaccination and COVID-19 therapeutics for PLHIV during the post-pandemic phase. Further research is however needed to understand the high risk of mortality in virally suppressed PLHIV with CD4\u2005\u2265\u2005200 cells\/\u03bcL.<\/jats:p>","DOI":"10.1097\/md.0000000000048202","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:01:49Z","timestamp":1775840509000},"page":"e48202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["High risk of COVID-19 mortality in people living with advanced HIV disease in South Africa: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-7391","authenticated-orcid":false,"given":"Seth","family":"Inzaule","sequence":"first","affiliation":[{"name":"Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4279-3056","authenticated-orcid":false,"given":"Jassat","family":"Waasila","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo","family":"Silva","sequence":"additional","affiliation":[{"name":"UNDP\/UNFPA\/UNICEF\/WHO\/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[{"name":"Department of Global HIV, STI, Hepatitis Programmes, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soe Soe","family":"Thwin","sequence":"additional","affiliation":[{"name":"UNDP\/UNFPA\/UNICEF\/WHO\/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-5735","authenticated-orcid":false,"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, Center for Clinical Microbiology, University College London; and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-7129","authenticated-orcid":false,"given":"Meg","family":"Doherty","sequence":"additional","affiliation":[{"name":"Department of Global HIV, STI, Hepatitis Programmes, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Diaz","sequence":"additional","affiliation":[{"name":"WHO Health Emergencies Programme, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8416-2581","authenticated-orcid":false,"given":"Silvia","family":"Bertagnolio","sequence":"additional","affiliation":[{"name":"Department of AMR Surveillance, Prevention and Control World Health Organization, Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"864838","DOI":"10.3389\/fimmu.2022.864838","article-title":"Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years\u2019 evidence summary.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4102\/sajhivmed.v22i1.1220","article-title":"Human immunodeficiency virus and mortality from coronavirus disease 2019: a systematic review and meta-analysis.","volume":"22","author":"Hariyanto","year":"2021","journal-title":"South Afr J HIV Med"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"e0238215","DOI":"10.1371\/journal.pone.0238215","article-title":"Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis.","volume":"15","author":"Ssentongo","year":"2020","journal-title":"PLoS One"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"183","DOI":"10.18433\/jpps32831","article-title":"The effect of HIV\/AIDS infection on the clinical outcomes of COVID-19: a meta-analysis.","volume":"25","author":"Moradi","year":"2022","journal-title":"J Pharm Pharm Sci"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12981-021-00427-y","article-title":"Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis.","volume":"19","author":"Danwang","year":"2022","journal-title":"AIDS Res Ther"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/S2352-3018(22)00097-2","article-title":"Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO global clinical platform of COVID-19.","volume":"9","author":"Bertagnolio","year":"2022","journal-title":"Lancet HIV"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2352-3018(23)00266-7","article-title":"Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data.","volume":"11","author":"Jassat","year":"2024","journal-title":"Lancet HIV"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10238-022-00840-1","article-title":"Significant association between HIV infection and increased risk of COVID-19 mortality: a meta-analysis based on adjusted effect estimates.","volume":"23","author":"Han","year":"2023","journal-title":"Clin Exp Med"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/iid3.497","article-title":"The clinical outcomes of COVID-19 in HIV-positive patients: a systematic review of current evidence.","volume":"9","author":"SeyedAlinaghi","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"R12-20260410","first-page":"e2005","article-title":"Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.","volume":"73","author":"Boulle","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jinf.2021.05.020","article-title":"Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19: HIV-positive and -negative patients with COVID-19.","volume":"83","author":"Venturas","year":"2021","journal-title":"J Infect"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"ofac579","DOI":"10.1093\/ofid\/ofac579","article-title":"A systematic review of COVID-19 vaccine antibody responses in people with HIV.","volume":"9","author":"Chun","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/vaccines10091569","article-title":"Immunogenicity and safety of COVID-19 vaccines among people living with HIV: a systematic review and meta-analysis.","volume":"10","author":"Kang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"e2215934","DOI":"10.1001\/jamanetworkopen.2022.15934","article-title":"Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States.","volume":"5","author":"Coburn","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"101360","DOI":"10.1016\/j.eclinm.2022.101360","article-title":"Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy.","volume":"46","author":"Gushchin","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijid.2022.11.035","article-title":"Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design.","volume":"127","author":"Fowokan","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/QAD.0000000000003405","article-title":"Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV.","volume":"36","author":"Chambers","year":"2022","journal-title":"AIDS"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(22)00007-1","article-title":"Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.","volume":"399","author":"Bekker","year":"2022","journal-title":"Lancet"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/hiv.13391","article-title":"Immune restoration affects 10-year survival in people living with HIV\/AIDS.","volume":"24","author":"Aksak-W\u0105s","year":"2023","journal-title":"HIV Med"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"106414","DOI":"10.1016\/j.jinf.2025.106414","article-title":"Clinical events associated with poor CD4+ T-cell recovery in people living with HIV following ART: a systematic review and meta-analysis.","volume":"90","author":"Mou","year":"2025","journal-title":"J Infect"},{"key":"R26-20260410","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12879-024-09112-7","article-title":"Mortality and associated factors among people living with HIV admitted at a tertiary-care hospital in Uganda: a cross-sectional study.","volume":"24","author":"Owachi","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R27-20260410","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11904-023-00647-z","article-title":"Immunologic interplay between HIV\/AIDS and COVID-19: adding fuel to the flames?","volume":"20","author":"Augello","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R28-20260410","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jiph.2022.05.006","article-title":"Risk of mortality in HIV-infected COVID-19 patients: a systematic review and meta-analysis.","volume":"15","author":"Dzinamarira","year":"2022","journal-title":"J Infect Public Health"},{"key":"R30-20260410","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s10461-022-03578-9","article-title":"Risk factors for COVID-19 mortality among people living with HIV: a scoping review.","volume":"26","author":"Varshney","year":"2022","journal-title":"AIDS Behav"},{"key":"R31-20260410","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/hiv.12911","article-title":"Coronavirus disease 2019 (COVID-19) outcomes in HIV\/AIDS patients: a systematic review.","volume":"21","author":"Cooper","year":"2020","journal-title":"HIV Med"},{"key":"R32-20260410","doi-asserted-by":"crossref","first-page":"1275843","DOI":"10.3389\/fmed.2023.1275843","article-title":"Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis.","volume":"10-2023","author":"Cheng","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R33-20260410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000529788","article-title":"High in-hospital mortality in SARS-CoV-2-infected patients with active cancer disease during omicron phase of the pandemic: insights from the CORONA Germany study.","volume":"46","author":"Konermann","year":"2023","journal-title":"Oncol Res Treat"},{"key":"R34-20260410","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1093\/cid\/ciac571","article-title":"Clinical characteristics and outcomes of immunocompromised patients with coronavirus disease 2019 caused by the omicron variant: a prospective, observational study.","volume":"76","author":"Malahe","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:50Z","timestamp":1785766910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":28,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048202","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2025-05-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}